Common Name(s): Argireline plus,snap-6,acetyl glutamyl hexapeptide-3 modified

CAS Number: 616204-22-9

DESCRIPTION

What It Does: Inhibits neuromuscular acetylcholine release for reduced facial muscle contraction and expression line formation.

Why It's Used: Enhanced argireline analog with improved stability for formulations requiring optimized neuro-inhibiting anti-wrinkle performance.

How It Works: Competes with snap-25 protein for binding to the snare complex, reducing vesicular acetylcholine release at neuromuscular junctions. reduced acetylcholine binding decreases muscle contraction amplitude, reducing expression line depth with repeated use.

Typically Found In: Anti-wrinkle creams,expression line treatments,forehead/eye area products

TECHNICAL DETAILS

Primary Category: Active ingredient – neurotransmitter-inhibiting peptide

Secondary Functions: Enhanced snare inhibition,improved stability

Application Areas:

Typical Concentration Range: 3–1000 ppm

SOURCING & ETHICS

Vegan Status: Yes – synthetic

Halal Status: Yes

Source Notes: Synthetically produced. encapsulation may improve delivery to neuromuscular junction.

SKIN COMPATIBILITY

Irritancy Rating: 1/5 – very low

Comedogenicity Rating: 0/5 – non-comedogenic

Sensitivity Concerns: Non-irritating.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Exceptional safety profile. ewg score: 1.

Works Well With: Hyaluronic acid,ceramides,retinol,moisturizers

Avoid Combining With: No significant incompatibilities

SCIENTIFIC NOTE

Hexapeptide-8 differs from argireline (hexapeptide-3) in its c-terminal modification that increases resistance to enzymatic degradation by skin proteases. this improved stability extends the bioavailability of the active peptide at the neuromuscular junction, potentially improving clinical anti-wrinkle efficacy vs the original argireline.

Last Verified: Cosing database,lipotec argireline plus data

Primary Sources: 2026-03-12